All HCCI Reports
Modern Healthcare: Targeting High-Risk Cancer Patients with Genetics
HCCI's research on utilization of preventive care services during the coronavirus pandemic was featured in Modern Healthcare.
From the article: "A Health Care Cost Institute analysis of data from various payers found mammograms were down 24% and colonoscopies were down 33% as of August."
Targeting high-risk cancer patients with genetics
As cancer screening rates have dwindled amid the COVID-19 pandemic, health systems like Adventist Health are using findings from genetic testing programs to ensure outreach to high-risk patients.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
©
2024
Health Care Cost Institute Inc. Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License
